Virnig Farms – FDA 483, Mar 7, 2023

The Food and Drug Administration (FDA) inspected the firm "aaieomyping" on March 7, 2023. The inspection revealed two primary observations indicating significant non-compliance with safe drug administration practices and record-keeping for food-producing animals. The first observation detailed an extralabel drug use resulting in a residue above the established safe level. Specifically, a cow was administered a treatment on August 14, 2022, and subsequently shipped for slaughter on August 22, 2022, which was before the drug's mandatory 13-day withdrawal period had elapsed. This practice directly led to an unsafe drug residue. The second critical observation was the complete absence of treatment records. The firm failed to maintain essential documentation for injectable drugs administered to cows on the dairy. Accurate and comprehensive record-keeping is fundamental for ensuring adherence to drug withdrawal times and preventing contaminated products from entering the food supply. These deficiencies highlight the company's need to implement immediate corrective actions, including revising drug administration protocols and establishing a robust record-keeping system, to ensure compliance with the Federal Food, Drug, and Cosmetic Act and safeguard public health.